214
Participants
Start Date
January 31, 2016
Primary Completion Date
June 30, 2021
Study Completion Date
June 30, 2021
Linezolid
Delamanid
Levofloxacin
Pyrazinamide
Locally-used WHO-approved MDR-TB regimen in Korea
Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine and Lung Institute of Medical Research Center, Seoul National University College of Medicine, Seoul
Collaborators (2)
Asan Medical Center
OTHER
Dankook University
OTHER
International Tuberculosis Research Center
OTHER
Pusan National University Yangsan Hospital
OTHER
Pusan National University Hospital
OTHER
Samsung Medical Center
OTHER
Severance Hospital
OTHER
SMG-SNU Boramae Medical Center
OTHER
Incheon St.Mary's Hospital
OTHER
Ulsan University Hospital
OTHER
Korean Institute of Tuberculosis
OTHER
National Medical Center, Seoul
OTHER
Korean Center for Disease Control and Prevention
OTHER_GOV
Korea University Ansan Hospital
OTHER
Seoul National University Hospital
OTHER